Teriflunomide, an immunomodulatory drug, exerts anticancer activity in triple negative breast cancer cells. Huang O, Zhang W, Zhi Q, Xue X, Liu H, Shen D, Geng M, Xie Z, Jiang M Exp Biol Med (Maywood). 2014 Oct 10. PMID: 25304315. Abstract CommentRecommendBookmarkWatch